Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 3:07 PM
Ignite Modification Date:
2025-12-25 @ 1:28 PM
NCT ID:
NCT03249792
Group ID:
EG026
Title:
Switch-over Arm 1 MK-2118 15000 µg IT To Arm 2 5400 µg IT + Pembrolizumab 200 mg IV
Description:
Qualified participants who received MK-2118 15000 µg via IT injection in Arm 1 but experienced disease progression switched over to Arm 2 and received combination therapy of MK-2118 5400 µg via IT injection Q1W on Days 1, 8 and 15 of Cycles 1-3 followed by Q3W on Day 1 of Cycle 4 and beyond, for a total of up to \~35 cycles (up to \~2 years) and pembrolizumab 200 mg via IV infusion on Day 1 of each cycle for up to \~35 cycles (up to \~2 years). Each cycle is 3 weeks long.
Deaths Number Affected:
1
Deaths Number At Risk:
None
Serious Number Affected:
0
Serious Number At Risk:
1
Other Number Affected:
0
Other Number At Risk:
1
Study:
NCT03249792
Results Section:
NCT03249792
Adverse Events Module:
NCT03249792